| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-08 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-08 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-07 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-06 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-06 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.16 | 8e-06 |